MBOT Microbot Medical Inc.

$1.55

Microbot Medical Inc. (MBOT) is expected to report earnings on November 10, 2026, before the market open. The consensus earnings estimate is a loss of $0.07 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -18.0% since its last earnings release on August 11, 2026.

Microbot Medical Reported In-line with Estimates
Tuesday, August 11, 2026 · 9:20 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 10
Tuesday · 8:30 AM ET
Earnings Whisper
-
vs ($0.07)
Rev est $880K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.62

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Microbot Medical Inc.

Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA.

Sector

Healthcare

Industry

Medical Instruments/Supply